Apr 20 2017

PepGel involved in $20 million project for regenerative medicine

PepGel LLC is proudly announcing its involvement in a $20 million project, led by Dr. Anthony Atala, director of Wake Forest Institute for Regenerative Medicine, to apply advanced manufacturing to regenerative medicine. The goal of this project is to speed up the availability of replacement tissues and organs to patients. One of the key objectives […]
Dec 23 2015

PepGel presents at the Smithsonian Innovation Festival 2015

PepGel was among the companies invited by the The Smithsonian National Museum of American History and the US Patent and Trademark Office to present at the 2015 Innovation Festival in Washington, DC on September 26-27. The Innovation Festival showcases organizations and companies that have made a significant step toward innovation The event returned for the […]
Oct 02 2015

Researchers showcase university invention at Smithsonian Innovation Festival

MANHATTAN — The spark of invention burned brightly for two Kansas State University researchers at the annual Smithsonian Innovation Festival in Washington, D.C. Xiuzhi “Susan” Sun, university distinguished professor of grain science and industry and biological and agricultural engineering, showed her patented PepGel, a biomaterial with special properties, to more than 22,500 festival visitors. T. […]
Jan 18 2015

PepGel chosen one of the 20 most promising biotech providers

PepGel LLC today announced that CIO Review (www.cioreview.com) has chosen PepGel for its “20 Most Promising Biotechnology Solution Providers”. This recognition is based on evaluation of PepGel’s capabilities in providing a transformational new method for 3D Cell Culture. The annual list of companies is selected by a distinguished panel of CEOs, CIOs, VCs and analysts, […]
Nov 19 2014

Patent issued for substance with medical benefits

MANHATTAN — A novel jelly-like substance developed by Kansas State University researchers was recently issued a U.S. patent. The substance may be used for biomedical applications, ranging from cell culture and drug delivery to repairing and replacing tissue, organs and cartilage. U.S. Patent No. 8,835,395, “Novel Protein Peptide Hydrogels,” was awarded to the Kansas State […]
Jun 21 2013

PepGel awarded NSF STTR phase I and phase IB Grant

This Small Business Technology Transfer (STTR) Phase I project aims to use a newly discovered peptide (h9e) hydrogel technology to provide an affordable and easy-to-use 3D cell culture system with high throughput screen and accurate in vivo representative. To bridge the fundamental understanding of cellular characteristics and the extensive complexity of tissue and organs, hydrogel […]

Social Links:

PepGel Linkedin page You_Tube_logo-90 px


PepGel LLC
1980 Kimball Avenue
Manhattan, KS 66506

Newsletter Subscribe: